Riskpilot← Back to searchSign inGet full accessOxThera AB
ABActiveOrg 5566815667Regeringsgatan 111Research and experimental development on natural sciences and engineering · NACE 7210Est. 20050 employees
Revenue 2024
SEK 0
EBITDA margin
—
+45% vs 2023
Equity ratio
98.8%
Financial strength
Net profit 2024
SEK -525K
+51% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -745K | +45% |
| Net profit | SEK -525K | +51% |
| Total assets | SEK 12M | -7% |
| Equity | SEK 11,8M | -4% |
| Employees | 0 | — |
Legal name
OxThera AB
Org number
5566815667
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
9 juni 2005
Share capital
SEK 21 124 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av Goldie, William John Fraser Stenström, Nils Johan Wallin, Mats Olof
Company purpose
Bolaget ska, självt eller genom dotterbolag, bedriva forskning och utveckling inom oxalatteknologi, marknadsföra och försälja produkter baserade på sådan teknologi, upplåta licenser avseende nämnda teknologi, äga och förvalta fast och lös egendom samt därmed förenlig verksamhet.
Address
Regeringsgatan 111
Email
mats-olof.wallin@oxthera.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 472 | 1 446 | 20 635 | 18 747 | 9 636 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 5 226 | −2 539 | −77 368 | −136 757 | −42 899 | −30 947 | 7 291 | −2 760 | −1 344 | −745 |
| Depreciation & amort. | −51 | −71 | −36 | −108 | −130 | −121 | −50 | −0 | −0 | −0 |
| EBIT | 5 175 | −2 610 | −77 404 | −136 865 | −43 029 | −31 068 | 7 241 | −2 760 | −1 344 | −745 |
| Net financials | −18 069 | −16 932 | −262 | 16 | −143 356 | −158 013 | −88 713 | −569 | 262 | 221 |
| Profit before tax | −12 894 | −19 542 | −77 666 | −136 849 | −186 385 | −189 081 | −81 472 | −3 329 | −1 082 | −525 |
| Tax | −0 | −0 | −9 | −44 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −12 894 | −19 542 | −77 675 | −136 893 | −186 385 | −189 081 | −81 472 | −3 329 | −1 082 | −525 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 75 935 | 199 109 | 112 029 | 114 574 | 94 570 | 74 182 | 19 388 | 13 926 | 12 809 | 11 976 |
| Equity | 20 738 | 189 126 | 93 729 | 90 243 | 11 615 | 12 415 | 16 765 | 13 436 | 12 354 | 11 829 |
| Long-term debt | 53 159 | 0 | 0 | 0 | 288 | 1 217 | 128 | 0 | 0 | 0 |
| Short-term debt | 2 038 | 9 983 | 18 260 | 24 331 | 82 667 | 60 550 | 2 495 | 490 | 455 | 147 |
| Total debt | 55 197 | 9 983 | 18 260 | 24 331 | 82 955 | 61 767 | 2 623 | 490 | 455 | 147 |
EBITDA margin
-74500000.0%
This company
15.8%
Market median
-471519087% vs market
20152024
Equity ratio
98.8%
This company
38.2%
Market median
+159% vs market
20152024
Return on equity
-4.4%
This company
18.4%
Market median
-124% vs market
20152024
Net profit margin
-52500000.0%
This company
8.1%
Market median
-648148248% vs market
20152024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20152024
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MO External Signatory | External Signatory | 2021 | — | — |
AF Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
HP Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
HP Chief Auditor | Chief Auditor | 2020 | — | — |
EO Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
MJ Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
KO External Signatory | External Signatory | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Deputy Board Member | 2024 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2020 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
OxThera AB 
OxThera Intellectual Property ABBoard members of OxThera AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mats Olof Wallin | External Signatory | 0 companies |
| Anders Fink Vadsholt | Chief Executive Officer | 0 companies |
| Hugo Petit | Chief Executive Officer | 0 companies |
| Hans Peter Ek | Chief Auditor | 0 companies |
| Edith Olga Elisabeth Lindner | Chief Executive Officer | 0 companies |
| Matthew John Gantz | Chief Executive Officer | 0 companies |
| Karl Ola Melin | External Signatory | 0 companies |
| Martijn Kleijwegt | Board of Directors | 0 companies |
| Nils Johan Stenström | Deputy Board Member | 0 companies |
| Georges Gemayel | Chairman | 0 companies |
| Rémi Pascal Louis Droller | Board of Directors | 0 companies |
| Sten Verland | Board of Directors | 0 companies |
| Jonas Karl Olof Brambeck | Deputy Board Member | 0 companies |
| William John Fraser Goldie | Board of Directors | 0 companies |
| Alain Henri Munoz | Board of Directors | 0 companies |
| Kirsti Gjellan | Board of Directors | 0 companies |
| Maarten De Chateau | Board of Directors | 0 companies |